Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.00
|
1.04
|
1.04
|
1.00
|
1.05
|
1.01
|
|
|
7 712.02
|
28.00
|
1.01
|
1.05
|
1.04
|
1.00
|
1.07
|
1.00
|
|
|
31 488.82
|
446.00
|
0.95
|
1.05
|
1.00
|
0.9785
|
1.06
|
1.04
|
|
|
11 652.31
|
99.00
|
0.982
|
1.00
|
1.02
|
0.9905
|
1.02
|
0.9905
|
|
|
2 795.37
|
37.00
|
0.9902
|
1.03
|
1.02
|
0.9734
|
1.02
|
0.9901
|
|
|
19 345.71
|
74.00
|
0.9911
|
1.04
|
1.01
|
1.00
|
1.01
|
1.00
|
|
|
789.10
|
29.00
|
0.9855
|
1.04
|
1.01
|
1.01
|
1.0397
|
1.0397
|
|
|
369.44
|
12.00
|
0.9801
|
1.06
|
1.06
|
1.01
|
1.07
|
1.045
|
|
|
14 899.82
|
107.00
|
0.97
|
1.04
|
1.02
|
0.941
|
1.04
|
1.0301
|
|
|
28 877.10
|
81.00
|
0.95
|
1.04
|
1.03
|
0.9993
|
1.03
|
1.00
|
|
|
18 338.27
|
61.00
|
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.